Skip to main content
Full access
Letter to the Editor
Published Online: 1 November 2005

Conclusions Inconsistent With Results With Amphetamines and Divalproex

To the Editor: In their article, Russell E. Scheffer, M.D., et al. (1) reported in their conclusions and elsewhere positive summary statements that included the following: “Pediatric patients with bipolar disorder and concurrent ADHD [attention deficit hyperactivity disorder] can be safely and effectively treated with mixed amphetamine salts after their manic symptoms are stabilized with divalproex sodium” (p. 58).
These ambitious claims were made by the authors after noting what they suggested to be these limitations of their brief trial: 1) ineffectively low doses of mixed amphetamine salts, 2) a failure to increase the divalproex doses to assess greater possible response, 3) the small group size, 4) a study protocol limited to a single academic center, and 5) a failure to address long-term outcomes and safety.
The authors’ statements regarding the efficacy/tolerability of mixed amphetamine salts/divalproex might be true, but their repetitively positive published conclusions are not consistent with their evidence. The announced conclusions, likewise, that appeared in the official publication of APA that reiterated this positive news (2) failed to disclose serious research limitations.
The expressed concerns of Dr. Scheffer and colleagues regarding the limitations of their study, while justified, did not address the serious problems in their research design and reporting:
1.
Twenty-five percent of the original subjects (N=40) did not have postrandomization data.
2.
At least four individuals in the study became manic, three of whom required hospitalization.
3.
The “treatment” period with mixed amphetamine salts was limited to a brief 14 days.
4.
An individual could be a positive responder with only one follow-up visit, despite being lost to follow-up thereafter.
5.
The 80% positive response rate reported with divalproex was unblinded and open label.
6.
The authors failed to disclose which treatment groups experienced “transient” side effects of “low to moderate severity and frequency.”
7.
At least one person treated with mixed amphetamine salts became manic.
8.
The authors included a misleading statement regarding the absence of worsening manic symptoms with treatment, and their Results section failed to provide information about other serious adverse reactions.
Published positive conclusions of this research effort, funded in part by a grant from the Stanley Medical Research Institute to Dr. Rush, are misleading. The Journal and Psychiatric News must be cautious about favorable generalizations from brief trials whose data from partially unblinded and open-label design do not include results from the research itself that demonstrate serious injuries (e.g., rehospitalizations and induction of mania) as a likely byproduct of the protocol. Representations of preliminary results should not suggest “safety and efficacy” when the data are limited and inconclusive.

References

1.
Scheffer RE, Kowatch RA, Carmody T, Rush AJ: Randomized, placebo-controlled trial of mixed amphetamine salts for symptoms of comorbid ADHD in pediatric bipolar disorder after mood stabilization with divalproex sodium. Am J Psychiatry 2005; 162:58–64
2.
Levin A: Kids with bipolar + ADHD respond to added stimulant. Psychiatr News, Jan 21, 2005, p 46

Information & Authors

Information

Published In

Go to American Journal of Psychiatry
Go to American Journal of Psychiatry
American Journal of Psychiatry
Pages: 2197
PubMed: 16263875

History

Published online: 1 November 2005
Published in print: November 2005

Authors

Details

STEFAN P. KRUSZEWSKI, M.D.
RICHARD PACZYNSKI, M.D.
Harrisburg, Pa.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

View Options

View options

PDF/EPUB

View PDF/EPUB

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - American Journal of Psychiatry

PPV Articles - American Journal of Psychiatry

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share